abs301.txt	purpose		studies	have	associated	increased	radiation	therapy	(rt)	heart	dose	withcardiac	toxicity		others	have	correlated	rt-related	immunosuppression	withworsened	survival		given	the	large	vascular	volumes	irradiated	during	locallyadvanced	non-small	cell	lung	cancer	(la-nsclc)	treatment		we	hypothesized	anassociation	between	increased	heart	dose	and	immunosuppression	methods		we	identified	400	la-nsclc	patients	treated	with	definitivert	±	chemotherapy	between	2001	and	2016		absolute	lymphocyte	counts	(alc)	absolute	neutrophil	counts	(anc)		and	neutrophil-to-lymphocyte	ratio(nlr	=	anc/alc)	were	analyzed	pre-rt		during	rt		and	post-rt		multivariableanalysis	(mva)	was	performed	to	correlate	clinical	factors	with	both	hematologictoxicity	and	overall	survival		an	upper	tertile	threshold	to	increase	specificityof	nlr	was	chosen	to	dichotomize	continuous	hematologic	variables	results		median	follow	up	was	17	months	(range	0	2-174	months)	in	all	patientsand	46	months	(range	0	2-161	months)	in	survivors		a	total	of	94%	of	patients	hadstage	iii	disease	and	77%	received	concurrent	chemo	radiation		two-year	overallsurvival	(os)		freedom	from	local	recurrence	(fflr)		and	freedom	from	distantmetastases	(ffdm)	was	42%		60%	and	45%		respectively		median	survival	was18	months		on	mva	for	os	(n	=	207)		male	gender	(hazard	ratio	[hr]	1	7		95%	ci1	2-2	3)		rt	alone	(hr	2	1		95%	ci	1	9-4	0)		the	percentage	of	heart	receiving≥50	gy	(v50)	(hr	1	02		95%	ci	1	01-1	03)		and	higher	nlr	at	4	months	(hr	1	02	95%	ci	1	01-1	03)	were	associated	with	reduced	os		alc	nadir	was	not	associatedwith	treatment	outcomes		nlr	>10	5	was	associated	with	decreased	os	(p	<	0	001)and	decreased	ffdm	(p	=	0	04)		on	mva	evaluating	factors	associated	withhematological	toxicity	(n	=	247)		adjuvant	chemotherapy	(hr	2	6		95%	ci	1	3-5	0	p	=	0	006)		rt	alone	(hr	3	6		95%	ci	1	1-12		p	=	0	04)		and	heart	v50	>25%	(hr2	0		95%	ci	1	1-3	5		p	=	0	02)	were	associated	with	a	nlr	>10	5	4	months	post-rt	conclusion		rt	related	immunosuppression	is	associated	with	worse	patientoutcomes		and	may	represent	a	source	of	increased	mortality	beyond	cardiactoxicity	alone	
